Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
GlobeNewswire
AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or..
AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or..
· Hemophilia Program: Ongoing registrational PRESent-2 and PRESent-3 studies of SerpinPC for the treatment of hemophilia B;..
*PRESS RELEASE*
*REGULATED INFORMATION – INSIDE INFORMATION*
*28 **March** 2024, 08:00 **a.m.** CET*
·..